Complete Conference Management 26th Annual San Diego Heart Failure Winter Symposium 2026

Advanced Heart Failure Prevention, Diagnosis & Management Update

The 26th Annual San Diego Heart Failure Winter Symposium 2026 provides a comprehensive review of contemporary heart failure management, focusing on prevention, early detection, risk stratification, guideline-directed therapy, advanced heart failure treatment, and emerging strategies designed to improve patient outcomes across the full spectrum of cardiovascular disease.

Organized by Complete Conference Management (CCM), this nationally recognized symposium brings together leading heart failure experts to discuss current and evolving approaches to the diagnosis, prevention, and treatment of heart failure in diverse patient populations.

Through expert-led lectures, case-based discussions, patient-centered learning, and moderated panel sessions, participants gain practical insights into evidence-based heart failure management ranging from cardiovascular-renal-metabolic syndrome (CRMS) and Stage A heart failure through advanced and end-stage disease.

📦 Course Features

• 53 Video Lectures
• 53 VTT Subtitle Files
• 40 PDF Presentations
• Total Size: 17.36 GB
• Recorded Symposium Sessions
• Expert Faculty Presentations
• Case-Based Learning
• Panel Discussions & Clinical Reviews
• Evidence-Based Heart Failure Education

👨‍⚕️ Target Audience

This course is ideal for:

• Cardiologists
• Internists
• Primary Care Physicians
• Family Medicine Physicians
• Nurse Practitioners
• Physician Assistants
• Pharmacists (PharmD)
• Cardiology Fellows
• Advanced Practice Providers
• Allied Healthcare Professionals

It is particularly valuable for clinicians seeking:

✔ Heart Failure Management Updates

✔ Guideline-Directed Medical Therapy (GDMT)

✔ Cardiovascular-Renal-Metabolic Syndrome (CRMS) Education

✔ Advanced Heart Failure Treatment Strategies

✔ Device-Based Heart Failure Therapy

✔ Prevention & Early Detection of Heart Failure

🧠 Program Overview

Heart failure remains one of the leading causes of hospitalization, morbidity, and mortality worldwide. Early recognition of at-risk patients and implementation of evidence-based therapies are critical for improving outcomes and reducing disease progression.

The 26th Annual San Diego Heart Failure Winter Symposium 2026 provides a practical review of contemporary approaches to heart failure prevention, diagnosis, and treatment across all stages of disease.

The program addresses the management of patients with cardiovascular-renal-metabolic syndrome (CRMS), asymptomatic structural heart disease, symptomatic heart failure, cardiogenic shock, and advanced or end-stage heart failure.

Participants review current guideline recommendations, emerging therapies, advances in device-based treatment, genetic causes of heart failure, and evolving strategies designed to improve long-term cardiovascular outcomes.

By integrating clinical case discussions, patient narratives, didactic lectures, and expert panel discussions, the symposium provides practical knowledge that can be immediately applied to everyday clinical practice.

🎯 Learning Objectives

Upon completion of this activity, participants will be able to:

• Summarize current and emerging therapies used to prevent and treat heart failure
• Select evidence-based treatment strategies for individual patients
• Implement guideline-directed medical therapy effectively
• Improve utilization of advanced heart failure therapies
• Evaluate the role of device-based interventions in heart failure management
• Recognize cardiovascular-renal-metabolic syndrome and associated risk factors
• Optimize management of patients with symptomatic heart failure
• Identify appropriate treatment approaches for advanced and end-stage heart failure
• Understand genetic and less common causes of heart failure
• Improve outcomes through individualized patient-centered care

🧩 Core Topics Covered

❤️ Heart Failure Prevention & Early Detection

The symposium reviews modern approaches to:

• Cardiovascular-Renal-Metabolic Syndrome (CRMS)
• Stage A & Stage B Heart Failure
• Risk Factor Modification
• Prevention of Clinical Heart Failure
• Early Diagnosis Strategies
• Population Health Approaches

💊 Guideline-Directed Medical Therapy (GDMT)

Participants explore evidence-based therapies including:

• SGLT2 Inhibitors
• ARNI Therapy
• Beta-Blockers
• Mineralocorticoid Receptor Antagonists
• Individualized Drug Selection
• Combination Therapy Strategies

🫀 Advanced Heart Failure Management

Dedicated sessions address:

• Advanced Heart Failure Evaluation
• End-Stage Heart Failure
• Cardiogenic Shock
• Mechanical Circulatory Support
• Referral Pathways
• Multidisciplinary Heart Failure Care

⚙️ Device-Based Therapies

Topics include:

• Cardiac Resynchronization Therapy (CRT)
• Implantable Cardioverter Defibrillators (ICD)
• Remote Monitoring Technologies
• Emerging Heart Failure Devices
• Patient Selection Strategies

🧬 Genetic & Special Populations

The program reviews:

• Genetic Cardiomyopathies
• Inherited Heart Failure Syndromes
• Heart Failure in Women
• Minority Populations
• Elderly Patients
• Personalized Treatment Approaches

🩺 Clinical Case Discussions

Real-world cases focus on:

• Complex Heart Failure Management
• Challenging Diagnostic Scenarios
• Medication Optimization
• Device Decision-Making
• Advanced Disease Management
• Patient-Centered Care Strategies

📚 Educational Features

✔ Evidence-Based Heart Failure Education

The curriculum integrates:

• Current Clinical Guidelines
• Emerging Heart Failure Therapies
• Case-Based Learning
• Interactive Clinical Discussions
• Expert Panel Reviews
• Practical Management Strategies

✔ Expert Faculty Insights

Participants learn from experienced heart failure specialists and cardiovascular experts with extensive clinical and research expertise.

✔ Real-World Clinical Application

The symposium emphasizes practical strategies that clinicians can immediately implement to improve diagnosis, treatment, and long-term management of heart failure patients.

⭐ Why This Course Stands Out

✔ Comprehensive Heart Failure Education Across All Disease Stages

✔ Strong Focus on Prevention & Early Detection

✔ Extensive Coverage of Emerging Drug & Device Therapies

✔ Practical Case-Based Learning

✔ Evidence-Based Clinical Updates

✔ Expert Faculty Perspectives

✔ Relevant for Both Specialists & Primary Care Clinicians

🚀 Clinical & Educational Value

The 26th Annual San Diego Heart Failure Winter Symposium 2026 provides a comprehensive update on the prevention, diagnosis, and treatment of heart failure.

By integrating guideline-directed medical therapy, advanced heart failure management, cardiovascular-renal-metabolic syndrome, device-based therapies, genetic heart disease evaluation, and patient-centered care strategies, this symposium equips clinicians with the knowledge needed to optimize outcomes across the entire spectrum of heart failure care.

The practical focus and multidisciplinary approach make this program highly valuable for cardiologists, internists, primary care physicians, and healthcare professionals involved in the management of cardiovascular disease.

Frequently Asked Questions

Is this course suitable for cardiologists?

Yes. The symposium provides comprehensive heart failure education highly relevant for practicing cardiologists, heart failure specialists, and cardiology fellows.

Does the course cover current heart failure guidelines?

Yes. The program reviews evidence-based guideline recommendations, emerging therapies, and practical treatment strategies for heart failure management.

Are advanced heart failure therapies discussed?

Yes. Dedicated sessions address advanced heart failure, cardiogenic shock, device-based therapies, and end-stage disease management.

Is this course useful for primary care physicians?

Absolutely. The program emphasizes prevention, early detection, risk-factor modification, and practical management strategies that are highly relevant to primary care practice.

 

+ Topics:

• 01 Recognizing the Cardio-Renal-Metabolic Syndrome (CRMS) and It’s Importance in Practice

• 02 Role of SGLT2 Inhibitors in Treating Patients with DCRM Conditions

• 03 Emerging Evidence that GLP-1 Agonists Can Prevent CV Disease in Patients with CRMS

• 04 Advances in the Management of Patients with Dyslipidemia

• 05 Use of Finerenone To Prevent CV Disease, CKD and Heart Failure

• 06 Moderated Panel

• 07 Percutaneous Valve Replacement and Repair

• 08 Advances in the Management of Pulmonary Arterial Hypertension

• 09 Recognizing and Treating Patients with Amyloidosis

• 10 Advances in the Management of Patients with Hypertrophic Cardiomyopathy

• 11 Managing Patients with Cardiac Sarcoidosis and Other Infiltrative Diseases

• 12 Moderated Panel Discussion

• 13 Introduction to Rare Diseases and Gene Therapy

• 14 Gene Therapy from Bench to Bedside

• 15 Genetic Testing – Who, What, When and Why

• 16 Genetic Counseling

• 17 Gene Therapy for Genetic Cardiomyopathies

• 18 Gene Therapy for Lysosomal Storage Diseases

• 19 Genetic Diseases from the Patient Perspective

• 20 Moderated Panel Discussion – Session 4

• 21 Advances in the Management of Patients with Symptomatic HFrEF

• 22 Emerging Approaches for Managing Patients with Symptomatic HFpEF

• 23 Monitoring Devices To Identify and Treat Congestion

• 24 What’s New in 2026

• 25 Moderated Panel Discussion – Session 5

• 26 Recognizing Preshock-The Early Warning Signs

• 27 Diagnosis and Initial Management of Cardiogenic Shock

• 28 Mechanical Circulatory Support in Escalating Shock

• 29 Surgical Intervention for Advanced Cardiogenic Shock

• 30 Moderated Panel Discussion – Session 6

• 31 Emerging Approaches for Categorizing and Treating Patients with Myocarditis and Chronic Pericarditis

• 32 Approaches for Managing Patients with Atrial Fibrillation and Preventing Thromboembolism

• 33 Chemotherapy Induced Cardiomyopathy- Prevalence, Risk and Prevention

• 34 Identifying Patients at Risk of Sudden Cardiac Death

• 35 Who Is A Candidate for Advanced Therapies

• 36 Outcomes From Cardiac Transplantation and LVAD

• 37 Moderated Panel Discussion – Session 8

• 38 Case Vignettes Cardiogenic shock in pregnancy

• 39 Clinical Vignettes Wettersten_Case

• 40 Case Vignettes Dixit_Case

• 41 Case Vignettes Shen_Case

• 42 Case Vignettes Taub_Cases

• 43 Case Vignettes

• Case Vignettes Day 1

• Clinical Vignettes Day 2

• Session I-Defining and Managing the Cardio-Renal-Metabolic Syndrome

• Session II- Cardio-Oncology and Pulmonary Arterial Hypertension

• Session III- Amyloid and Other Infiltrative Heart Disease, Hypertrophic Cardiomyopathy and HFpEF

• Session IV- Rare Diseases and Gene Therapy

• Session V- Managing Patients with Stage C Heart Failure

• Session VI- Shock and Pre-Shock- Diagnosis and Management

• Session VII- Myocarditis, Pericarditis, Arrhythmias, Treating Valvular Heart Disease and Preventing Sudden Cardiac…

• Session VIII- Advanced Therapies for Heart Failure